Dexter J L Hayes
Overview
Explore the profile of Dexter J L Hayes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Godhard E, Michelotti F, Hayes D, Heazell A
Eur J Obstet Gynecol Reprod Biol
. 2025 Jan;
306:29-34.
PMID: 39787963
Introduction: Fetal scalp blood sampling (FSBS) can be used as an adjunctive test, in the presence of a pathological intrapartum fetal heart rate trace, to provide evidence of fetal acidaemia....
2.
Bradford B, Hayes D, Damhuis S, Shub A, Akselsson A, Radestad I, et al.
Int J Gynaecol Obstet
. 2023 Dec;
165(2):579-585.
PMID: 38064233
Maternal reports of decreased fetal movement (DFM) are a common reason to present to maternity care and are associated with stillbirth and other adverse outcomes. Promoting awareness of fetal movements...
3.
Hayes D, Devane D, Dumville J, Gordijn S, Smith V, Walsh T, et al.
BJOG
. 2023 Jul;
131(1):64-70.
PMID: 37394688
Objective: This study aimed to create core outcome sets (COSs) for use in research studies relating to the awareness and clinical management of reduced fetal movement (RFM). Design: Delphi survey...
4.
Hayes D, Dumville J, Walsh T, Higgins L, Fisher M, Akselsson A, et al.
Am J Obstet Gynecol MFM
. 2022 Dec;
5(3):100821.
PMID: 36481411
Objective: Reduced fetal movement, defined as a decrease in the frequency or strength of fetal movements as perceived by the mother, is a common reason for presentation to maternity care....
5.
Brien M, Gaudreault V, Hughes K, Hayes D, Heazell A, Girard S
J Clin Med
. 2022 Jan;
11(1).
PMID: 35011965
Blockade of the interleukin-1 (IL-1) pathway has been used therapeutically in several inflammatory diseases including arthritis and cryopyrin-associated periodic syndrome (CAPS). These conditions frequently affect women of childbearing age and...
6.
Hayes D, Devane D, Dumville J, Smith V, Walsh T, Heazell A
Trials
. 2021 Dec;
22(1):894.
PMID: 34886899
Background: Concerns regarding reduced fetal movements (RFM) are reported in 5-15% of pregnancies, and RFM are associated with adverse pregnancy outcomes including fetal growth restriction and stillbirth. Studies have aimed...
7.
Tamber K, Hayes D, Carey S, Wijekoon J, Heazell A
PLoS One
. 2020 Dec;
15(12):e0242983.
PMID: 33259507
Background: Antepartum fetal monitoring aims to assess fetal development and wellbeing throughout pregnancy. Current methods utilised in clinical practice are intermittent and only provide a 'snapshot' of fetal wellbeing, thus...
8.
Hayes D, Warland J, Parast M, Bendon R, Hasegawa J, Banks J, et al.
PLoS One
. 2020 Sep;
15(9):e0239630.
PMID: 32970750
Objective: Current data on the role of the umbilical cord in pregnancy complications are conflicting; estimates of the proportion of stillbirths due to cord problems range from 3.4 to 26.7%....
9.
Sharps M, Hayes D, Lee S, Zou Z, Brady C, Almoghrabi Y, et al.
Placenta
. 2020 Sep;
101:13-29.
PMID: 32911234
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, was first identified after a cluster of cases in Wuhan, China in December 2019. Whether vertical transmission or placental...
10.
Scott R, Greenwood S, Hayes D, Baker B, Jones R, Heazell A
Reprod Toxicol
. 2019 May;
87:50-59.
PMID: 31082466
Hydroxychloroquine (HCQ), a toll like receptor (TLR) 7 and 9 antagonist, is used during pregnancy for inflammatory conditions with limited understanding of its placental toxicology. We hypothesized that HCQ does...